NCT04649931View on ClinicalTrials.gov

Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease)

CompletedOBSERVATIONAL

Enrollment

450

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

April 25, 2021

Study Completion Date

April 25, 2021

Conditions

SARS (Severe Acute Respiratory Syndrome)Covid19

Interventions

DEVICE

Ion Mobility Spectrometry (IMS)

Two breathing gas samples will be taken from each study participant using ion mobility spectrometry with an ultrasound-based spirometer. The total sampling time is 1 minute (at least 5-7 breath takes) following an analysis time of 5-12 minutes.

Trial Locations (1)

Unknown

University Hospital Gießen and Marburg (UKGM), site Marburg, Marburg

All Listed Sponsors

collaborator

CeGaT GmbH

UNKNOWN

lead

B. Braun Melsungen AG

INDUSTRY

NCT04649931 - Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease) | Biotech Hunter | Biotech Hunter